Cerus Corp (CERS)

Cerus Corp insiders executed nine transactions totaling approximately 1.18 million dollars in sales over the past ninety days. Key executives, including the CEO and CFO, offloaded shares through planned divestments. These activities occurred following the most recent earnings report, while the stock price maintains a moderate position within its annual trading range.
Ticker: CERS Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cerus Corp. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
Jensen Chrystal Chief Legal Officer Officer
Transaction date
Planned sale
Price
13.83
Quantity 90,596 +20.1%
Value US$3,321,918
2.7
CHRYSTAL NIKOLE JENSEN Officer Officer
Transaction date
Proposed sale
Price
290.71
Quantity 15,218
Value US$2,747,699
2.2
Jayaraman Vivek K Chief Executive Officer Officer
Transaction date
Planned sale
Price
454.66
Quantity 89,190 +41.8%
Value US$2,005,761
2.2
VIVEK K JAYARAMAN Officer Officer
Transaction date
Proposed sale
Price
3.16
Quantity 16,666
Value US$52,665
2.8
Green Kevin Dennis Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.94
Quantity 33,676 -3.1%
Value US$99,105
2.2
Jayaraman Vivek K Chief Operating Officer Officer
Transaction date
Planned sale
Price
2.94
Quantity 42,359 -2.4%
Value US$124,658
2.7
Jensen Chrystal Chief Legal Officer Officer
Transaction date
Planned sale
Price
2.94
Quantity 24,329 -2.5%
Value US$71,598
2.8
Greenman William Mariner President and CEO Executive Director
Transaction date
Planned sale
Price
2.94
Quantity 101,919 -2.0%
Value US$299,937
2.8
Greenman William Mariner President and CEO Executive Director
Transaction date
Planned sale
Price
2.94
Quantity 101,919 -2.0%
Value US$299,937
3.2
BJERKHOLT ERIC Non-Executive Director
Transaction date
Sale
Price
2.60
Quantity 20,454 -7.2%
Value US$53,180
3.2
ERIC BJERKHOLT Director Non-Executive Director
Transaction date
Proposed sale
Price
2.60
Quantity 20,454
Value US$53,180
3.2
ERIC BJERKHOLT Director Non-Executive Director
Transaction date
Proposed sale
Price
2.60
Quantity 20,454
Value US$53,180
2.2
Jayaraman Vivek K Chief Operating Officer Officer
Transaction date
Planned sale
Price
3.00
Quantity 16,667 -1.0%
Value US$50,001
2.2
VIVEK K JAYARAMAN Officer Officer
Transaction date
Proposed sale
Price
3.00
Quantity 16,667
Value US$50,001
2.2
Jayaraman Vivek K Chief Operating Officer Officer
Transaction date
Planned sale
Price
3.00
Quantity 16,667 -1.0%
Value US$50,001
2.2
VIVEK K JAYARAMAN Officer Officer
Transaction date
Proposed sale
Price
3.00
Quantity 16,667
Value US$50,001
2.4
RICHARD J BENJAMIN Officer Officer
Transaction date
Proposed sale
Price
2.82
Quantity 76,209
Value US$214,627
2.2
Jayaraman Vivek K Chief Operating Officer Officer
Transaction date
Planned sale
Price
1.66
Quantity 165,200 -8.6%
Value US$273,769
2.8
Greenman William Mariner President and CEO Executive Director
Transaction date
Planned sale
Price
1.66
Quantity 447,757 -8.2%
Value US$742,023
2.8
Green Kevin Dennis Chief Financial Officer Officer
Transaction date
Planned sale
Price
1.66
Quantity 127,544 -10.9%
Value US$211,366
2.4
Benjamin Richard J Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.66
Quantity 101,740 -11.6%
Value US$168,604
2.4
Benjamin Richard J Chief Medical Officer Officer
Transaction date
Sale
Price
1.88
Quantity 40,426 -4.4%
Value US$76,029
2.4
RICHARD J BENJAMIN Officer Officer
Transaction date
Proposed sale
Price
1.88
Quantity 40,426
Value US$76,029
2.8
Greenman William Mariner President and CEO Executive Director
Transaction date
Planned sale
Price
2.01
Quantity 78,187 -1.4%
Value US$156,804
2.4
Benjamin Richard J Chief Medical Officer Officer
Transaction date
Planned sale
Price
2.01
Quantity 24,235 -2.6%
Value US$48,603
2.7
Jensen Chrystal Chief Legal Officer Officer
Transaction date
Planned sale
Price
2.01
Quantity 30,845 -2.8%
Value US$61,860
2.8
Green Kevin Dennis Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.01
Quantity 27,796 -2.3%
Value US$55,745
2.2
Jayaraman Vivek K Chief Operating Officer Officer
Transaction date
Planned sale
Price
2.01
Quantity 34,094 -1.8%
Value US$68,376
2.4
Benjamin Richard J Chief Medical Officer Officer
Transaction date
Sale
Price
2.06
Quantity 61,233 -6.1%
Value US$126,305
2.8
Green Kevin Dennis Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.06
Quantity 55,225 -4.4%
Value US$113,902
2.8
KEVIN D GREEN Officer Officer
Transaction date
Proposed sale
Price
2.06
Quantity 55,225
Value US$113,902
2.4
RICHARD J BENJAMIN Officer Officer
Transaction date
Proposed sale
Price
2.06
Quantity 61,233
Value US$126,299
2.7
Jensen Chrystal Chief Legal Officer Officer
Transaction date
Sale
Price
1.70
Quantity 55,000 -7.0%
Value US$93,500
2.7
CHRYSTAL NIKOLE JENSEN Officer Officer
Transaction date
Proposed sale
Price
1.70
Quantity 55,000
Value US$93,500
3.5
Gregory Dean A. Non-Executive Director
Transaction date
Purchase
Price
1.25
Quantity 25,000 +40.5%
Value US$31,250
2.7
Jensen Chrystal Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.45
Quantity 30,075 -3.7%
Value US$43,609
2.2
Jayaraman Vivek K Chief Operating Officer Officer
Transaction date
Planned sale
Price
1.45
Quantity 46,004 -3.1%
Value US$66,706
2.8
Greenman William Mariner President and CEO Executive Director
Transaction date
Planned sale
Price
1.45
Quantity 122,827 -2.9%
Value US$178,099
2.4
Benjamin Richard J Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.45
Quantity 30,075 -4.2%
Value US$43,609
2.8
Green Kevin Dennis Chief Financial Officer Officer
Transaction date
Planned sale
Price
1.45
Quantity 36,740 -4.0%
Value US$53,273
2.7
Jensen Chrystal Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.45
Quantity 18,949 -2.3%
Value US$27,476
2.2
Jayaraman Vivek K Chief Operating Officer Officer
Transaction date
Planned sale
Price
1.45
Quantity 29,985 -2.0%
Value US$43,478
2.8
Greenman William Mariner President and CEO Executive Director
Transaction date
Planned sale
Price
1.45
Quantity 71,086 -1.6%
Value US$103,075
2.4
Benjamin Richard J Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.45
Quantity 18,949 -2.6%
Value US$27,476
2.8
Green Kevin Dennis Chief Financial Officer Officer
Transaction date
Planned sale
Price
1.45
Quantity 23,147 -2.5%
Value US$33,563
2.7
Jensen Chrystal Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.66
Quantity 113,008 -10.7%
Value US$187,277
2.8
Greenman William Mariner President and CEO Executive Director
Transaction date
Planned sale
Price
1.50
Quantity 60,984 -1.4%
Value US$91,354
2.4
Benjamin Richard J Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.50
Quantity 26,139 -3.4%
Value US$39,156
2.8
Green Kevin Dennis Chief Financial Officer Officer
Transaction date
Planned sale
Price
1.50
Quantity 31,148 -3.2%
Value US$46,660
2.7
Jensen Chrystal Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.50
Quantity 27,457 -3.2%
Value US$41,131
2.2
Jayaraman Vivek K Chief Operating Officer Officer
Transaction date
Planned sale
Price
1.50
Quantity 33,999 -2.2%
Value US$50,931
2.7
Jensen Chrystal Chief Legal Officer Officer
Transaction date
Sale
Price
1.59
Quantity 60,000 -12.9%
Value US$95,142
2.7
Jensen Chrystal Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.55
Quantity 6,292 -1.3%
Value US$9,743
2.2
Jayaraman Vivek K Chief Operating Officer Officer
Transaction date
Planned sale
Price
1.55
Quantity 10,780 -1.2%
Value US$16,693
2.4
Benjamin Richard J Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.55
Quantity 6,292 -1.6%
Value US$9,743
2.8
Green Kevin Dennis Chief Financial Officer Officer
Transaction date
Planned sale
Price
1.55
Quantity 8,386 -1.5%
Value US$12,986
2.8
Greenman William Mariner President and CEO Executive Director
Transaction date
Planned sale
Price
1.55
Quantity 23,023 -0.7%
Value US$35,651
2.7
Jensen Chrystal Officer Officer
Transaction date
Proposed sale
Price
1.50
Quantity 60,000
Value US$90,000
2.4
Benjamin Richard J Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.58
Quantity 51,254 -11.3%
Value US$80,828
2.8
Green Kevin Dennis Chief Financial Officer Officer
Transaction date
Planned sale
Price
1.58
Quantity 60,656 -10.9%
Value US$95,673
2.4
RICHARD J BENJAMIN Officer Officer
Transaction date
Proposed sale
Price
1.58
Quantity 51,254
Value US$80,822
2.8
KEVIN D GREEN Officer Officer
Transaction date
Proposed sale
Price
1.58
Quantity 60,656
Value US$95,646
2.7
CHRYSTAL NIKOLE JENSEN Officer Officer
Transaction date
Proposed sale
Price
1.72
Quantity 16,667
Value US$28,626
2.7
Jensen Chrystal Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.71
Quantity 16,667 -3.5%
Value US$28,501
3.5
Gregory Dean A. Non-Executive Director
Transaction date
Purchase
Price
1.70
Quantity 1,725 +2.9%
Value US$2,932
3.2
BJERKHOLT ERIC Non-Executive Director
Transaction date
Sale
Price
1.79
Quantity 20,000 -11.0%
Value US$35,700
3.2
BJERKHOLT ERIC Director Non-Executive Director
Transaction date
Proposed sale
Price
1.79
Quantity 20,000
Value US$35,700
2.8
Green Kevin Dennis Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.15
Quantity 54,272 -9.2%
Value US$116,826
2.8
KEVIN D GREEN Officer Officer
Transaction date
Proposed sale
Price
2.15
Quantity 54,272
Value US$116,826
2.8
Green Kevin Dennis Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.18
Quantity 28,385 -4.6%
Value US$61,919
2.8
KEVIN D GREEN Officer Officer
Transaction date
Proposed sale
Price
2.18
Quantity 28,385
Value US$61,919
2.7
Jensen Chrystal Chief Legal Officer Officer
Transaction date
Planned sale
Price
2.07
Quantity 16,667 -3.4%
Value US$34,417
2.7
CHRYSTAL NIKOLE JENSEN Officer Officer
Transaction date
Proposed sale
Price
2.07
Quantity 16,667
Value US$34,427
2.4
Benjamin Richard J Chief Medical Officer Officer
Transaction date
Planned sale
Price
2.50
Quantity 21,605 -4.7%
Value US$54,012
2.4
RICHARD J BENJAMIN Officer Officer
Transaction date
Proposed sale
Price
2.50
Quantity 21,605
Value US$54,012
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-17 2026-08-17 PlS Planned sale

Chief Legal Officer

Officer
90,596 +20.1%
13.83
US$3,321,918
90,596 +20.1% 13.83 US$3,321,918
2026-08-17 2026-08-17 PrS Proposed sale

Officer

Officer
15,218
290.71
US$2,747,699
15,218 290.71 US$2,747,699
2026-07-20 2026-07-16 PlS Planned sale

Chief Executive Officer

Officer
89,190 +41.8%
454.66
US$2,005,761
89,190 +41.8% 454.66 US$2,005,761
2026-07-16 2026-07-16 PrS Proposed sale

Officer

Officer
16,666
3.16
US$52,665
16,666 3.16 US$52,665
2026-07-02 2026-06-30 PlS Planned sale

Chief Financial Officer

Officer
33,676 -3.1%
2.94
US$99,105
33,676 -3.1% 2.94 US$99,105
2026-07-02 2026-06-30 PlS Planned sale

Chief Operating Officer

Officer
42,359 -2.4%
2.94
US$124,658
42,359 -2.4% 2.94 US$124,658
2026-07-02 2026-06-30 PlS Planned sale

Chief Legal Officer

Officer
24,329 -2.5%
2.94
US$71,598
24,329 -2.5% 2.94 US$71,598
2026-07-02 2026-06-30 PlS Planned sale

President and CEO

Executive Director
101,919 -2.0%
2.94
US$299,937
101,919 -2.0% 2.94 US$299,937
2026-07-02 2026-06-30 PlS Planned sale

President and CEO

Executive Director
101,919 -2.0%
2.94
US$299,937
101,919 -2.0% 2.94 US$299,937
2026-06-11 2026-06-09 S Sale Non-Executive Director
20,454 -7.2%
2.60
US$53,180
20,454 -7.2% 2.60 US$53,180
2026-06-09 2026-06-09 PrS Proposed sale

Director

Non-Executive Director
20,454
2.60
US$53,180
20,454 2.60 US$53,180
2026-06-09 2026-06-09 PrS Proposed sale

Director

Non-Executive Director
20,454
2.60
US$53,180
20,454 2.60 US$53,180
2026-06-02 2026-05-29 PlS Planned sale

Chief Operating Officer

Officer
16,667 -1.0%
3.00
US$50,001
16,667 -1.0% 3.00 US$50,001
2026-05-29 2026-05-29 PrS Proposed sale

Officer

Officer
16,667
3.00
US$50,001
16,667 3.00 US$50,001
2026-05-05 2026-05-01 PlS Planned sale

Chief Operating Officer

Officer
16,667 -1.0%
3.00
US$50,001
16,667 -1.0% 3.00 US$50,001
2026-05-01 2026-05-01 PrS Proposed sale

Officer

Officer
16,667
3.00
US$50,001
16,667 3.00 US$50,001
2026-05-01 2026-05-01 PrS Proposed sale

Officer

Officer
76,209
2.82
US$214,627
76,209 2.82 US$214,627
2026-03-16 2026-03-12 PlS Planned sale

Chief Operating Officer

Officer
165,200 -8.6%
1.66
US$273,769
165,200 -8.6% 1.66 US$273,769
2026-03-16 2026-03-12 PlS Planned sale

President and CEO

Executive Director
447,757 -8.2%
1.66
US$742,023
447,757 -8.2% 1.66 US$742,023
2026-03-16 2026-03-12 PlS Planned sale

Chief Financial Officer

Officer
127,544 -10.9%
1.66
US$211,366
127,544 -10.9% 1.66 US$211,366
2026-03-16 2026-03-12 PlS Planned sale

Chief Medical Officer

Officer
101,740 -11.6%
1.66
US$168,604
101,740 -11.6% 1.66 US$168,604
2026-03-09 2026-03-09 S Sale

Chief Medical Officer

Officer
40,426 -4.4%
1.88
US$76,029
40,426 -4.4% 1.88 US$76,029
2026-03-09 2026-03-09 PrS Proposed sale

Officer

Officer
40,426
1.88
US$76,029
40,426 1.88 US$76,029
2026-03-09 2026-03-06 PlS Planned sale

President and CEO

Executive Director
78,187 -1.4%
2.01
US$156,804
78,187 -1.4% 2.01 US$156,804
2026-03-09 2026-03-06 PlS Planned sale

Chief Medical Officer

Officer
24,235 -2.6%
2.01
US$48,603
24,235 -2.6% 2.01 US$48,603
2026-03-09 2026-03-06 PlS Planned sale

Chief Legal Officer

Officer
30,845 -2.8%
2.01
US$61,860
30,845 -2.8% 2.01 US$61,860
2026-03-09 2026-03-06 PlS Planned sale

Chief Financial Officer

Officer
27,796 -2.3%
2.01
US$55,745
27,796 -2.3% 2.01 US$55,745
2026-03-09 2026-03-06 PlS Planned sale

Chief Operating Officer

Officer
34,094 -1.8%
2.01
US$68,376
34,094 -1.8% 2.01 US$68,376
2026-03-09 2026-03-05 S Sale

Chief Medical Officer

Officer
61,233 -6.1%
2.06
US$126,305
61,233 -6.1% 2.06 US$126,305
2026-03-09 2026-03-05 PlS Planned sale

Chief Financial Officer

Officer
55,225 -4.4%
2.06
US$113,902
55,225 -4.4% 2.06 US$113,902
2026-03-05 2026-03-05 PrS Proposed sale

Officer

Officer
55,225
2.06
US$113,902
55,225 2.06 US$113,902
2026-03-05 2026-03-05 PrS Proposed sale

Officer

Officer
61,233
2.06
US$126,299
61,233 2.06 US$126,299
2025-11-26 2025-11-24 S Sale

Chief Legal Officer

Officer
55,000 -7.0%
1.70
US$93,500
55,000 -7.0% 1.70 US$93,500
2025-11-24 2025-11-24 PrS Proposed sale

Officer

Officer
55,000
1.70
US$93,500
55,000 1.70 US$93,500
2025-08-25 2025-08-25 B Purchase Non-Executive Director
25,000 +40.5%
1.25
US$31,250
25,000 +40.5% 1.25 US$31,250
2025-03-17 2025-03-14 PlS Planned sale

Chief Legal Officer

Officer
30,075 -3.7%
1.45
US$43,609
30,075 -3.7% 1.45 US$43,609
2025-03-17 2025-03-14 PlS Planned sale

Chief Operating Officer

Officer
46,004 -3.1%
1.45
US$66,706
46,004 -3.1% 1.45 US$66,706
2025-03-17 2025-03-14 PlS Planned sale

President and CEO

Executive Director
122,827 -2.9%
1.45
US$178,099
122,827 -2.9% 1.45 US$178,099
2025-03-17 2025-03-14 PlS Planned sale

Chief Medical Officer

Officer
30,075 -4.2%
1.45
US$43,609
30,075 -4.2% 1.45 US$43,609
2025-03-17 2025-03-14 PlS Planned sale

Chief Financial Officer

Officer
36,740 -4.0%
1.45
US$53,273
36,740 -4.0% 1.45 US$53,273
2025-03-17 2025-03-13 PlS Planned sale

Chief Legal Officer

Officer
18,949 -2.3%
1.45
US$27,476
18,949 -2.3% 1.45 US$27,476
2025-03-17 2025-03-13 PlS Planned sale

Chief Operating Officer

Officer
29,985 -2.0%
1.45
US$43,478
29,985 -2.0% 1.45 US$43,478
2025-03-17 2025-03-13 PlS Planned sale

President and CEO

Executive Director
71,086 -1.6%
1.45
US$103,075
71,086 -1.6% 1.45 US$103,075
2025-03-17 2025-03-13 PlS Planned sale

Chief Medical Officer

Officer
18,949 -2.6%
1.45
US$27,476
18,949 -2.6% 1.45 US$27,476
2025-03-17 2025-03-13 PlS Planned sale

Chief Financial Officer

Officer
23,147 -2.5%
1.45
US$33,563
23,147 -2.5% 1.45 US$33,563
2026-03-16 2025-03-12 PlS Planned sale

Chief Legal Officer

Officer
113,008 -10.7%
1.66
US$187,277
113,008 -10.7% 1.66 US$187,277
2025-03-10 2025-03-07 PlS Planned sale

President and CEO

Executive Director
60,984 -1.4%
1.50
US$91,354
60,984 -1.4% 1.50 US$91,354
2025-03-10 2025-03-07 PlS Planned sale

Chief Medical Officer

Officer
26,139 -3.4%
1.50
US$39,156
26,139 -3.4% 1.50 US$39,156
2025-03-10 2025-03-07 PlS Planned sale

Chief Financial Officer

Officer
31,148 -3.2%
1.50
US$46,660
31,148 -3.2% 1.50 US$46,660
2025-03-10 2025-03-07 PlS Planned sale

Chief Legal Officer

Officer
27,457 -3.2%
1.50
US$41,131
27,457 -3.2% 1.50 US$41,131
2025-03-10 2025-03-07 PlS Planned sale

Chief Operating Officer

Officer
33,999 -2.2%
1.50
US$50,931
33,999 -2.2% 1.50 US$50,931
2025-03-05 2025-03-04 S Sale

Chief Legal Officer

Officer
60,000 -12.9%
1.59
US$95,142
60,000 -12.9% 1.59 US$95,142
2025-03-05 2025-03-04 PlS Planned sale

Chief Legal Officer

Officer
6,292 -1.3%
1.55
US$9,743
6,292 -1.3% 1.55 US$9,743
2025-03-05 2025-03-04 PlS Planned sale

Chief Operating Officer

Officer
10,780 -1.2%
1.55
US$16,693
10,780 -1.2% 1.55 US$16,693
2025-03-05 2025-03-04 PlS Planned sale

Chief Medical Officer

Officer
6,292 -1.6%
1.55
US$9,743
6,292 -1.6% 1.55 US$9,743
2025-03-05 2025-03-04 PlS Planned sale

Chief Financial Officer

Officer
8,386 -1.5%
1.55
US$12,986
8,386 -1.5% 1.55 US$12,986
2025-03-05 2025-03-04 PlS Planned sale

President and CEO

Executive Director
23,023 -0.7%
1.55
US$35,651
23,023 -0.7% 1.55 US$35,651
2025-03-04 2025-03-04 PrS Proposed sale

Officer

Officer
60,000
1.50
US$90,000
60,000 1.50 US$90,000
2025-03-05 2025-03-03 PlS Planned sale

Chief Medical Officer

Officer
51,254 -11.3%
1.58
US$80,828
51,254 -11.3% 1.58 US$80,828
2025-03-05 2025-03-03 PlS Planned sale

Chief Financial Officer

Officer
60,656 -10.9%
1.58
US$95,673
60,656 -10.9% 1.58 US$95,673
2025-03-03 2025-03-03 PrS Proposed sale

Officer

Officer
51,254
1.58
US$80,822
51,254 1.58 US$80,822
2025-03-03 2025-03-03 PrS Proposed sale

Officer

Officer
60,656
1.58
US$95,646
60,656 1.58 US$95,646
2024-12-16 2024-12-16 PrS Proposed sale

Officer

Officer
16,667
1.72
US$28,626
16,667 1.72 US$28,626
2024-12-16 2024-12-16 PlS Planned sale

Chief Legal Officer

Officer
16,667 -3.5%
1.71
US$28,501
16,667 -3.5% 1.71 US$28,501
2025-01-02 2024-12-13 B Purchase Non-Executive Director
1,725 +2.9%
1.70
US$2,932
1,725 +2.9% 1.70 US$2,932
2024-12-16 2024-12-12 S Sale Non-Executive Director
20,000 -11.0%
1.79
US$35,700
20,000 -11.0% 1.79 US$35,700
2024-12-12 2024-12-12 PrS Proposed sale

Director

Non-Executive Director
20,000
1.79
US$35,700
20,000 1.79 US$35,700
2024-09-05 2024-09-04 PlS Planned sale

Chief Financial Officer

Officer
54,272 -9.2%
2.15
US$116,826
54,272 -9.2% 2.15 US$116,826
2024-09-04 2024-09-04 PrS Proposed sale

Officer

Officer
54,272
2.15
US$116,826
54,272 2.15 US$116,826
2024-09-05 2024-09-03 PlS Planned sale

Chief Financial Officer

Officer
28,385 -4.6%
2.18
US$61,919
28,385 -4.6% 2.18 US$61,919
2024-09-03 2024-09-03 PrS Proposed sale

Officer

Officer
28,385
2.18
US$61,919
28,385 2.18 US$61,919
2024-08-19 2024-08-15 PlS Planned sale

Chief Legal Officer

Officer
16,667 -3.4%
2.07
US$34,417
16,667 -3.4% 2.07 US$34,417
2024-08-15 2024-08-15 PrS Proposed sale

Officer

Officer
16,667
2.07
US$34,427
16,667 2.07 US$34,427
2024-08-07 2024-08-02 PlS Planned sale

Chief Medical Officer

Officer
21,605 -4.7%
2.50
US$54,012
21,605 -4.7% 2.50 US$54,012
2024-08-02 2024-08-02 PrS Proposed sale

Officer

Officer
21,605
2.50
US$54,012
21,605 2.50 US$54,012